Clinical Trial Update: Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 neoadjuvant study combining a PD-1 inhibitor with an EGFR inhibitor for locally advanced cutaneous squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• EGFR inhibitor
• PD-1 inhibitor

Snippet

Sponsor: Melanoma and Skin Cancer Trials Limited | Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING